{"nct_id":"NCT05221840","title":"A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-02-07","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2030-07-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}